# Trade Mark Journal No.2025/038 19 September 2025

## UK00004261958 10 September 2025 (5,9,42,44)

International priority date claimed: 7 August 2025 (United States of America) (99326306)

Class 5
  Biological chemical test kits for medical laboratory use, in analysis of gene expression, and transplant rejection or tolerance.
Class 9
  Downloadable computer application software for mobile devices, namely, software for monitoring and management of patient healthcare information and data.
Class 42
  Providing online non-downloadable software for monitoring and managing patient healthcare information and data; Software as a service (SAAS) services featuring software that monitors and manages patient healthcare information and data.
Class 44
  Medical diagnostic services, namely, gene expression testing to determine immune response; medical diagnostic services, namely, cell-free DNA testing for medical purposes; medical diagnostic testing, namely, donor-specific cell-free DNA testing to determine immune response and transplant rejection or tolerance; medical diagnostic testing services, namely, blood-based testing to determine immune response and transplant rejection or tolerance.

CareDx, Inc.

Representative: Kunze Rechtsanwälte _ Solicitor (England & Wales) PartG mbB